Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine (2021)

First Author: Payne R

Attributed to: Investigation of proven vaccine breakthrough by SARS-CoV-2 variants in established UK healthcare worker cohorts: SIREN consortium & PITCH Plus Pathway funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cell.2021.10.011

Publication URI: http://dx.doi.org/10.1016/j.cell.2021.10.011

Type: Journal Article/Review

Parent Publication: Cell

Issue: 23